Solventum Corp (SOLV) Stock AnalysisSOLVStock AnalysisSolventum Corp

Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation. It operates in the Healthcare sector.

Solventum Corp is a strong buy at the current price of $91.12, supported by a recent earnings report that showed a 9.5% year-over-year organic growth and an EPS of $2.55, which exceeded estimates by 33.51%. The company's forward P/E ratio of 13.39 suggests it is undervalued compared to its growth potential. However, the main risk is its high debt-to-equity ratio of 110.12%, which could impact financial stability if not managed carefully.